Educational research tool. Not investment advice. You are responsible for your own trading decisions.

Verdix.
← All analysis

Nokia Oyj (NOKIA)

Verdict history · NOKIA

Every call Verdix has made on NOKIA.

While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.

Click any date below to read that write-up

WaitBalanced· Aug 22, 2026

The shift from WAIT to BALANCED reflects price action, not a change in the business thesis. At \€9.23 the stock was still searching for a bottom; at \€8.76 it has settled just below the monthly 50% Fibonacci retracement at \€8.85 and within striking distance of the weekly EMA50 at \€8.04. The prior BUY trigger, a pullback to the \€7.93 to \€8.01 zone with MACD turning up, did not fire, but the price is now close enough to key support that existing holders gain nothing by selling. The business story is unchanged: the \€2.8B AI backlog remains the central variable, and the panel's conviction has not risen because no new data on conversion has arrived since Q2.

See methodology for how verdicts are produced. Full track record →

The panel’s split verdict on NOKIA — and where they disagree.

BalancedMEDIUM confidence

The case for and against roughly balance — no clear edge at today's price.

Nasdaq Helsinki · Technology / Telecom Equipment · 2026-08-22 · analysis, not advice

Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.

Verdict

Balanced

MEDIUM confidence

Why

Nokia's \€2.8B AI order backlog is real, the balance sheet is clean, and insiders are buying. But with free cash flow still negative and the forward P/E at 24.5x, the panel splits between one bull who sees 14% to 31% upside, one bear who rejects the business quality outright, and four neutrals who need either a better price or a confirmed reversal before committing new capital.

Level to watch

Key resistance 8.85

+1.0% from 8.76

Next catalyst

Trigger to confirm the correction is over: A weekly close above €9.30, which would reclaim the weekly EMA20 and the 50% weekly Fibonacci level, confirming the pullback has exhausted itself.

The panel's take

Verdict: BALANCED · Conviction: MEDIUM · Last price: 8.76 · Changed from WAIT

Panel: 1 Bullish · 4 Neutral · 1 Bearish → BALANCED

What changed since 2026-08-15:

  • Price: 9.23 → 8.76 (-5.09%)
  • Panel: 2 of 5 → 1 of 6 now Bullish — composition also changed: added The Activist Catalyst, The Structural Tailwind Rider; removed The Asymmetric Bargainer
  • Trigger: A weekly close above €9.30 (reclaim of weekly EMA20 and 50% weekly Fib) would confirm the correction is over and flip this to BUY. A weekly close below €7.96 (weekly 61.8% Fib + EMA50 zone) would break the Stage 2 uptrend structure and flip this to SELL. The prior article's BUY trigger — pullback to €7.93–€8.01 with MACD turning up — still stands and was not met.
  • Verdict: WAIT → BALANCED

The shift from WAIT to BALANCED reflects price action, not a change in the business thesis. At €9.23 the stock was still searching for a bottom; at €8.76 it has settled just below the monthly 50% Fibonacci retracement at €8.85 and within striking distance of the weekly EMA50 at €8.04. The prior BUY trigger, a pullback to the €7.93 to €8.01 zone with MACD turning up, did not fire, but the price is now close enough to key support that existing holders gain nothing by selling. The business story is unchanged: the €2.8B AI backlog remains the central variable, and the panel's conviction has not risen because no new data on conversion has arrived since Q2.

BALANCED, not WAIT, because price has dropped from €9.23 to €8.76, landing just below the monthly 50% Fib (€8.85) and close enough to key support that existing holders should sit tight — but the prior BUY trigger (pullback to €7.93–€8.01 or reclaim of €9.50) did not fire, and the weekly MACD is still deteriorating, so committing new capital is premature. The sole bull (The Intrinsic-Value Modeler) sees value at these levels; the sole bear (The Quality Rationalist) rejects the business quality entirely; the four neutrals all want a better price or a confirmed reversal — and neither has arrived yet.

Key levels

Key levels · NOKIA

EUR · as of 2026-08-22
Analyst consensus 10.32
R310.3
+17.6%
R29.43
+7.6%
R18.85
+1.0%
S18.04
−8.2%
S27.96
−9.1%
S37.39
−15.6%
NOW
8.76

Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.

Key support at €8.04 (weekly EMA50, the intermediate trend line that has held throughout this pullback) and €7.96 (weekly 61.8% Fib golden ratio — the line the technical scout flagged as the decisive bull/bear boundary). Key resistance at €8.85 (monthly 50% Fib, the immediate battle zone where price is now probing) and €9.30–€9.43 (weekly 50% Fib plus the weekly EMA20 — a zone the stock must reclaim to confirm the correction is over, and the level the prior article's breakout trigger demanded). The analyst consensus target of €10.32 sits above all near-term resistance, implying ~18% upside if the AI conversion story delivers.

What legendary investors think

We ran Nokia Oyj past a panel of 6 legendary investors' frameworks.

The panel · 6 investors

🟢
1
Bullish
⚫
4
Neutral
🔴
1
Bearish
The Forensic SkepticContrarian/Forensic⚫ NeutralLow

Signal: The balance sheet carries net cash of €1.77B against a debt/equity ratio of 0.16, and insiders bought €872K in shares at €8.44 in July, yet the forward P/E of 24.54x prices in the recovery consensus already expects, leaving no margin of safety for a business with a 3.45% ROE. Conviction: The absence of tangible book value data and order conversion history means there is no calculable margin of safety, and at 2.3x book value with a 3.45% ROE, the asset-value floor is too far below the current €8.76 to provide protection.

The GARP OperatorGrowth (GARP)⚫ NeutralMed

Signal: The €2.8B AI order backlog is 6.3x quarterly revenue and insiders bought €872K in shares at €8.44 right after Q2 results, yet the PEG ratio of 1.08 sits at the boundary of fair value for a turnaround: neither cheap nor expensive if the growth materializes. Conviction: What keeps conviction in check is the dependency on AI backlog conversion, a process the CEO himself describes as lumpy and supply-constrained; if the conversion rate disappoints in Q3, the PEG of 1.08 quickly becomes irrelevant because the growth assumption collapses.

The Quality RationalistMental Models/Quality🔴 BearishLow

Signal: The company generates a 3.45% ROE, well below its cost of capital, operates in a mature cyclical industry with intense rivalry from Ericsson and Huawei, and trades at 24.5x forward earnings, a premium multiple for a business that has not earned its cost of capital through multiple cycles. Conviction: The view is anchored by a 3.45% ROE that has not budged through multiple restructuring cycles; a business that cannot earn its cost of capital over a full cycle does not deserve a 24.5x forward multiple, regardless of how large the order book looks.

The Intrinsic-Value ModelerValuation/DCF🟢 BullishMed

Signal: The €2.8B AI order book represents 6.3x quarterly revenue with roughly half converting within 12 months, and my base-case DCF puts intrinsic value at €10.00 to €11.50, implying 14% to 31% upside from €8.76, provided the restructuring outflows of €700M to €800M in 2026 do not extend further. Conviction: Conviction is held back by the reality that Q2 free cash flow was negative €732M and restructuring outflows of €700M to €800M in 2026 mean the AI backlog may convert to revenue without converting to cash, leaving the DCF dependent on an unproven FCF inflection.

The Structural Tailwind RiderGrowth / Structural Themes⚫ NeutralMed

Signal: The €2.8B AI data-center interconnect backlog aligns with India's 5G infrastructure buildout and rising mobile data consumption, and three executives deploying €872K of their own capital at €8.44 signals management conviction in the turnaround, although the business quality score of 6/10 with a 3.45% ROE falls short of a high-conviction compounder. Conviction: Enthusiasm is muted because Nokia lacks a direct India-centric competitive advantage; the AI data-center story is global, not local, and the business quality score of 6/10 with a 3.45% ROE falls short of the high-return compounding machines this framework prioritizes.

The Activist CatalystActivist/Capital Allocation⚫ NeutralMed

Signal: Management is credible, insiders bought at €8.44, and the net cash balance sheet provides a floor, yet trailing free cash flow of just €535M on €20.4B in revenue yields only 2.6%. This is not a simple, predictable, FCF-generative business, and the forward P/E of 24.5x already embeds the recovery. Conviction: The gap between the 2.6% trailing FCF yield and the 24.5x forward multiple is too wide to ignore; management is credible and the balance sheet is clean, but without a clear capital-allocation catalyst such as a substantial buyback program, the stock is likely to trade range-bound until earnings materialize.

Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.

Where they agree — and where they clash

Common ground

  • The €2.8B AI order backlog (6.3x quarterly revenue) is real and material: no panelist disputes the demand signal, even if they disagree on what it is worth.
  • The balance sheet is clean: net cash of €1.0B to €2.5B, debt/equity of 0.16, and a current ratio of 1.51 provide a floor under the stock that limits catastrophic downside.
  • Insider buying of €872K at €8.44 in July 2026 is read as a meaningful positive signal across all six archetypes.
  • The trailing P/E of 74x is a trough-earnings artifact; all six agree the forward P/E of roughly 24.5x is the relevant multiple for the recovery debate.

The real debate

  • The Quality Rationalist dismisses the business as low-quality (3.45% ROE, narrow moat) and sees no price that fixes that, while The Intrinsic-Value Modeler argues the AI backlog transforms the earnings stream and justifies a €10.00 to €11.50 intrinsic value.
  • The GARP Operator sees a PEG of 1.08 as fair value for a turnaround with a credible catalyst, while The Forensic Skeptic insists a 24.5x forward multiple leaves no margin of safety for a cyclical equipment vendor with an unproven conversion timeline.
  • The Activist Catalyst and The Structural Tailwind Rider both acknowledge the story's potential but hold back: one wants multi-year FCF guidance before committing, the other sees insufficient India-specific competitive advantage to warrant high conviction.

The question it comes down to: Can Nokia convert the €2.8B AI order backlog into sustained free cash flow before restructuring outflows consume the narrative, and will Q3 2026 show the first real evidence of that conversion in reported revenue?

The bottom line

  • Trigger to confirm the correction is over: A weekly close above €9.30, which would reclaim the weekly EMA20 and the 50% weekly Fibonacci level, confirming the pullback has exhausted itself.
  • Support to defend: A weekly close below €7.96 would breach the weekly 61.8% Fibonacci and EMA50 zone, breaking the Stage 2 uptrend structure.
  • Next catalyst: Q3 2026 earnings in late October: sequential revenue growth of 3% to 7% is guided, and the first signs of AI backlog conversion into reported revenue will either validate or undermine the thesis.
  • Risk to monitor: Free cash flow turned negative €732M in Q2 due to restructuring outflows of €700M to €800M in 2026; if these outflows extend into 2027, the conversion story loses credibility.
  • Historical accumulation zone: The prior article's trigger, a pullback to the €7.93 to €8.01 zone with weekly MACD turning up, remains unfilled and represents the zone where the last major buyers accumulated.

contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in NOKIA · NOKIA verdict history → · Methodology →

Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Stay ahead of NOKIA's next verdict

The panel's view can flip on new earnings, a guidance cut, or a valuation shift. Get the update the moment it happens — not weeks later.

One email, only on a verdict change. Unsubscribe anytime.